62 U Wisara Road, Yangon, Myanmar
Servier, an international pharmaceutical group governed by a non-profit foundation. We are focused on cardiovascular diseases, diabetes, neuropsychiatric diseases andcommitted to therapeutic progress to serve patient needs. We contribute to transmit to future generations a world that can ensure access to quality health care for all. With 64 million patients treated worldwide by our medicinal products on a daily basis, we are keenly aware of our responsibilities to patients, doctors, and healthcare professionals. They are the motivating force behind our daily drive for innovation as a provider of therapeutic progress.
With a strong international presence in 148 countries and a turnover of 4 billion euros in 2016, we employ 21,000 people worldwide. Entirely independent, we reinvest 25% of our turnover (excluding generic drugs) in research and development and use all our profits for development. Currently, we have 35 drug candidates including 22 new molecular entities at various stages of clinical development. Our priorities are pathologies with high medical needs within our areas of expertise.
